ClinicalTrials.Veeva

Menu

Multiple Arm Study of Sebacia Microparticles in the Treatment of Acne Vulgaris

S

Sebacia

Status

Completed

Conditions

Acne Vulgaris

Treatments

Device: Sebacia microparticle and laser treatment
Device: Vehicle and laser treatment

Study type

Interventional

Funder types

Industry

Identifiers

NCT02219074
SEB-0005

Details and patient eligibility

About

Prospective, multicenter study with multiple arms to examine the safety and effectiveness of the Sebacia Acne Treatment System for the treatment of acne vulgaris.

Enrollment

350 patients

Sex

All

Ages

16 to 35 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • clinical diagnosis of moderate to severe acne vulgaris

Exclusion criteria

  • use of oral retinoid therapy in the past 12 months
  • pregnancy, lactating, or planning to become pregnant
  • excessive scarring in the treatment area, or other condition that would impact the ability to evaluate acne

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

350 participants in 2 patient groups

Sebacia microparticle and laser treatment
Experimental group
Treatment:
Device: Sebacia microparticle and laser treatment
Vehicle and laser treatment
Sham Comparator group
Treatment:
Device: Vehicle and laser treatment

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems